🇺🇸 FDA
Patent

US 10479993

Modulation of signal transducer and activator of transcription 3 (STAT3) expression

granted A61PA61P21/00A61P35/00

Quick answer

US patent 10479993 (Modulation of signal transducer and activator of transcription 3 (STAT3) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P21/00, A61P35/00, A61P35/04, A61P43/00